Erickson emerges from Chapter 11 bankruptcy, completes sale to private firm

The sale of Erickson Retirement Communities LLC, which manages 19 full-service campus-style communities, to Redwood Capital Investments, has been completed, the senior living provider disclosed Monday. The company also has emerged from Chapter 11 bankruptcy, it said.

“The sale of Erickson to Redwood and confirmation of our Plan of Reorganization concludes a very difficult and extremely complicated period in Erickson's history,” said Guy Sansone, who served as chief restructuring officer, in a statement.

Erickson, which gained a strong reputation over the years for its deluxe communities and refundable deposits, filed for bankruptcy protection last October. The filing was a way for the company to restructure its debt and reorganize its core management and real estate businesses into separate but commonly owned legal and financial entities. John Erickson is the founder of Erickson Retirement Communities.

The company took a financial hit when the economic downturn prevented potential residents from selling their homes and moving into the communities. Redwood is a private investment firm. Jim Davis controls it.

More in News

Government initiatives aim to decrease number of disabled people in nursing homes

Government initiatives aim to decrease number of disabled ...

The federal government is ramping up efforts to reduce the number of disabled people in nursing homes through interagency initiatives. While many disabled people have already been moved out of ...

Nursing home optometrist faces False Claims suit alleging excessive, unreasonable eye exams ...

An optometrist in Kentucky defrauded Medicare and Medicaid by filing claims for nursing home care that was unnecessary or not provided, alleges a False Claims Act lawsuit recently brought by the federal government.

Fecal transplants to treat C. diff now need FDA approval

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.